DR Horton Inc (DHI)

Return on equity (ROE)

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Net income (ttm)	US$ in thousands	4,734,400	4,745,700	4,867,800	5,180,500	5,674,600	5,857,500	5,564,700	5,032,400	4,525,600	4,175,800	3,665,800	3,181,000	2,734,200	2,373,700	2,050,000	1,894,100	1,762,700	1,618,600	1,579,400	1,558,400
Total stockholders’ equity	US$ in thousands	23,153,400	22,696,200	21,656,400	20,712,700	20,153,300	19,396,300	18,062,500	16,774,900	15,677,700	14,886,500	13,802,900	12,963,100	12,485,200	11,840,000	11,048,000	10,458,000	10,227,400	10,020,900	9,642,400	9,360,300
ROE		20.45%	20.91%	22.48%	25.01%	28.16%	30.20%	30.81%	30.00%	28.87%	28.05%	26.56%	24.54%	21.90%	20.05%	18.56%	18.11%	17.24%	16.15%	16.38%	16.65%

December 31, 2023 calculation

ROE = Net income (ttm) ÷ Total stockholders’ equity
= $4,734,400K ÷ $23,153,400K
= 20.45%

D.R. Horton Inc.'s return on equity (ROE) has shown a declining trend over the past eight quarters, dropping from 30.81% in Q2 2022 to 20.45% in Q4 2023. This downward trajectory may be indicative of a decrease in the company's profitability compared to its equity base. The ROE measures the company's ability to generate profits from the shareholders' equity, and the declining trend observed may require further investigation into the company's financial performance, capital structure, and operational efficiency.